Ann Marie Navar (Ann M Navar)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Atrial Fibrillation

Clinical Decision Support

Cardiovascular Disease

Oral Anticoagulants

Top Venues

Journal of the American Heart Association

Clinical cardiology

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Weerapat Kositanurit, John M Giacona, Donglu Xie, Jijia Wang, Daniel Feuer, Kyle J O'Malley, Ann Marie Navar, Anand Vaidya, Jordana B Cohen, Wanpen Vongpatanasin
Trends in Primary Aldosteronism Screening Among High-Risk Hypertensive Adults. Journal of the American Heart Association 13 (15) (2024)
Joanna N Assadourian, Eric D Peterson, Anand Gupta, Ann Marie Navar
Use of Dietary Supplements Among People With Atherosclerotic Cardiovascular Disease in the United States: A Population-Based Analysis From NHANES. Journal of the American Heart Association 13 (9) (2024)
Samuel D Slavin, Adam N Berman, Andrew L Beam, Ann Marie Navar, Murray A Mittleman
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. Journal of the American Heart Association 13 (7) (2024)
Joanna N Assadourian, Eric D Peterson, Anand Gupta, Ann Marie Navar
Use of Dietary Supplements Among People With Atherosclerotic Cardiovascular Disease in the United States: A Population-Based Analysis From NHANES. Journal of the American Heart Association 13 (9) (2024)
Samuel D Slavin, Adam N Berman, Andrew L Beam, Ann Marie Navar, Murray A Mittleman
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. Journal of the American Heart Association 13 (7) (2024)
Joanna N Assadourian, Eric D Peterson, Anand Gupta, Ann Marie Navar
Use of Dietary Supplements Among People With Atherosclerotic Cardiovascular Disease in the United States: A Population-Based Analysis From NHANES. Journal of the American Heart Association (2024)
Samuel D Slavin, Adam N Berman, Andrew L Beam, Ann Marie Navar, Murray A Mittleman
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. Journal of the American Heart Association (2024)
Samuel D Slavin, Adam N Berman, Andrew L Beam, Ann Marie Navar, Murray A Mittleman
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. Journal of the American Heart Association 13 (7) (2024)
Samuel D Slavin, Adam N Berman, Andrew L Beam, Ann Marie Navar, Murray A Mittleman
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. Journal of the American Heart Association 13 (7) (2024)
Weerapat Kositanurit, John M Giacona, Donglu Xie, Jijia Wang, Daniel Feuer, Kyle J O'Malley, Ann Marie Navar, Anand Vaidya, Jordana B Cohen, Wanpen Vongpatanasin
Trends in Primary Aldosteronism Screening Among High-Risk Hypertensive Adults. Journal of the American Heart Association (2024)
Samuel D Slavin, Adam N Berman, Andrew L Beam, Ann Marie Navar, Murray A Mittleman
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. Journal of the American Heart Association 13 (7) (2024)
Parag H Joshi, Khurram Nasir, Ann Marie Navar
When Opportunity Knocks: Capitalizing on Incidental Coronary Arterial Calcification. Circulation 147 (9) (2023)
Ijeoma Eleazu, Colby R Ayers, Ann Marie Navar, Karim Salhadar, Michelle A Albert, Mercedes R Carnethon, Sherwood Brown, Lucy Ogbu Nwobodo, Spencer Carter, Courtney Bess, Tiffany M Powell-Wiley, James A de Lemos
Associations of Cumulative Perceived Stress with Cardiovascular Risk Factors and Outcomes: Findings from The Dallas Heart Study. medRxiv : the preprint server for health sciences (2023)
Parag H Joshi, Khurram Nasir, Ann Marie Navar
When Opportunity Knocks: Capitalizing on Incidental Coronary Arterial Calcification. Circulation 147 (9) (2023)
Daniel A Salmon, Stanley Plotkin, Ann Marie Navar
Vaccine Decision-making in a Time of Conflicting Recommendations: A Call to Go Beyond Politics. The Pediatric infectious disease journal (2023)
Ann Marie Navar, Ahmed A Kolkailah, Anand Gupta, Kristin Khalaf Gillard, Marc K Israel, Yiqing Wang, Eric D Peterson
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients. Circulation. Cardiovascular quality and outcomes (2023)
Austin Deets, Parag H Joshi, Alvin Chandra, Kavisha Singh, Amit Khera, Salim S Virani, Christie M Ballantyne, James D Otvos, Robin P F Dullaart, Eke G Gruppen, Margery A Connelly, Colby R Ayers, Ann Marie Navar, Ambarish Pandey, John T Wilkins, Anand Rohatgi
Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. Journal of the American Heart Association (2023)
Ann Marie Navar, Ahmed A Kolkailah, Robert Overton, Nishant P Shah, Justin F Rousseau, Greg C Flaker, Michael P Pignone, Eric D Peterson
Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. Journal of the American Heart Association 11 (22) (2022)
Corey K Bradley, Amit Khera, Ann Marie Navar
Underdiagnosis of familial hypercholesterolaemia: innovation is overdue. European heart journal 43 (34) (2022)
Ann Marie Navar, Stacey N Purinton, Qingjiang Hou, Robert J Taylor, Eric D Peterson
The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19. PloS one 16 (7) (2021)
Angela Lowenstern, Shuang Li, Ann Marie Navar, Salim S Virani, Veronique L Roger, Jennifer G Robinson, Anne C Goldberg, Wendy Kampman, Eric D Peterson, Tracy Y Wang
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry. Clinical cardiology 44 (6) (2021)
Ann Marie Navar, Simon T Matskeplishvili, Miguel Urina-Triana, Mohammed Arafah, Jaw-Wen Chen, Apichard Sukonthasarn, Valérie Corp Dit Genti, Véronique Daclin, Eric D Peterson
Prospective evaluation of lipid management following acute coronary syndrome in non-Western countries. Clinical cardiology 44 (7) (2021)